Date: Tuesday, June 27, 2023 7:00 pm - 8:30 pm
June 27, 2023
7:00 pm - 8:00 pm
- Assess the efficacy, safety, and mechanism of action of non-statin agents approved to manage LDL-C levels
- Devise individualized evidence-based primary prevention plans for patients with elevated LDL-C levels
- Develop personalized strategies for secondary prevention for patients with elevated LDL-C levels using evidence-based guidelines
- Escalate treatment of elevated LDL-C levels by incorporating approved non-statin agents when statins alone do not achieve 2018 blood cholesterol guideline goals
Attendance is free, but registration is required. Register Today!
The AAFP has reviewed Managing Elevated LDL-C Levels to Reduce ASCVD Risk: Primary and Secondary Prevention, and deemed it acceptable for AAFP credit. Term of approval is from 04/04/2023 to 08/01/2023. Physicians should claim only the credit commensurate with the extent of their participation in the activity.